1-20 of 66
eosinophilic leukemia, chronic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Charcot-Leyden crystals in chronic eosinophilic leukemia

Yorick Sandberg, Floor Weerkamp
Journal: Blood
Blood (2021) 137 (14): 1985.
https://doi.org/10.1182/blood.2020010648
Published: 2021
Journal Articles

JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera

Ami B. Patel, Anca Franzini, Emilie Leroy, Soo Jin Kim, Anthony D. Pomicter, Lidvine Genet, Michael Xiao, Dongqing Yan, Jonathan M. Ahmann, Archana M. Agarwal, Phillip Clair, Juanah Addada, Jonathan Lambert, Matthew Salmon, Gerald J. Gleich, Nicholas C. P. Cross, Stefan N. Constantinescu, Thomas O’Hare, Josef T. Prchal, Michael W. Deininger
Journal: Blood
Blood (2019) 134 (26): 2388–2398.
https://doi.org/10.1182/blood.2019001385
Published: 2019
Includes: Supplemental data
Journal Articles

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Julien Rohmer, MD, Matthieu Groh, MD, Julie Trichereau, Kewin Panel, Claude Preudhomme, PharmD, PhD, Fanny Legrand, PhD PharmD, Felix Ackermann, MD, Amélie Couteau-Chardon, MD, Mikael Ebbo, MD PhD, Olivier Fain, MD, Lionel Galicier, MD, Mohamed Hamidou, Mathilde Hunault, MD PhD, Etienne Lengline, MD, Catherine Mohr, MD, Franck E Nicolini, MD PhD, Jerome Rey, Louis Terriou, MD, Chafika Morati Hafsaoui, MD, Suzanne Tavitian, MD, Irene Machelart, Katayoun Jondeau, MD, Bertrand Arnulf, Jean-Christophe Ianotto, MD PhD, Jean-Marc Zini, Viviane Dubruille, MD, Francoise Huguet, MD, Borhane Slama, MD, Fabrice Jardin, Didier Adiko, Elise Toussaint, MD, Aurelien Guffroy, MD PhD, Faustine Lhomme, MD PhD, Nathalie Grardel, Cyrielle Gesquieres, Guillaume Lefèvre, MD PhD, Jean Emmanuel Kahn, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 840.
https://doi.org/10.1182/blood-2019-130009
Published: 2019
Journal Articles

Epidemiology of Patients with Classical Philadelphia-Chromosome Negative Myeloproliferative Neoplasms at a Single Academic Medical Center in Singapore

Priscella Shirley Chia, BSc, Vanessa CL Chong, Ting Yuan Tay, Eng Soo Yap, MBBS, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Xin Liu, Moon Ley Tung, MBBS, MRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 5478.
https://doi.org/10.1182/blood-2018-99-116728
Published: 2018
Journal Articles

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Matthew K Stein, MD, Dilan Patel, MD, Andrew Hahn, MD, Jamie Riney, MD, Michael G. Martin, MD
Journal: Blood
Blood (2016) 128 (22): 1935.
https://doi.org/10.1182/blood.V128.22.1935.1935
Published: 2016
Journal Articles

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Antonella Orlando, Ilaria Casetti, MD, Chiara Elena, MD, Elisa Rumi, MD, Mario Cazzola, MD
Journal: Blood
Blood (2016) 128 (22): 5493.
https://doi.org/10.1182/blood.V128.22.5493.5493
Published: 2016
Journal Articles

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

Jason Gotlib, MD MS, Hanneke C. Kluin-Nelemans, MD PhD, Tracy I. George, MD, Cem Akin, MD PhD, Karl Sotlar, MD, Olivier Hermine, MD PhD, Farrukh Awan, MD MS, Elizabeth O Hexner, MD, Michael Mauro, MD, David Sternberg, MD PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, Eric Stanek, PharmD, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD
Journal: Blood
Blood (2014) 124 (21): 636.
https://doi.org/10.1182/blood.V124.21.636.636
Published: 2014
Journal Articles

Use of Crispr/Cas Genome Editing in Ba/F3 Cells to Generate the Fip1l1-Pdgfra and Nup214-Abl1 Fusion Genes

Marlies Vanden Bempt, Msc, Charles E de Bock, PhD, Nicole Mentens, Olga Gielen, Ellen Geerdens, Sofie Demeyer, PhD, Jan Cools, PhD
Journal: Blood
Blood (2014) 124 (21): 3575.
https://doi.org/10.1182/blood.V124.21.3575.3575
Published: 2014
Journal Articles

SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor (IL-3R), Possesses Preclinical Cytotoxic Activity Against Chronic Eosinophilic Leukemia

Christopher Brooks, PhD, Vincent Macri, Arnaldo Albini, MD, Ivan Bergstein, MD, Eric Rowinsky, MD
Journal: Blood
Blood (2013) 122 (21): 4104.
https://doi.org/10.1182/blood.V122.21.4104.4104
Published: 2013
Journal Articles

Chronic eosinophilic leukemia with FIP1L1-PDGFRA

Jose Verdu, Francisco de Paz
Journal: Blood
Blood (2013) 121 (8): 1254.
https://doi.org/10.1182/blood-2012-09-458224
Published: 2013
Journal Articles

A Novel FOXP1-PDGFRA Fusion Gene in A Case of Chronic Eosinophilic Leukemia.

Yuka Sugimoto, MD, PhD, Akiko Sada, MD, PhD, Fumihiko Monma, MD, PhD, Kohshi Ohishi, MD, PhD, Masahiro Masuya, MD, PhD, Toshimitsu Matsui, MD, PhD, Naoyuki Katayama, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2830.
https://doi.org/10.1182/blood.V120.21.2830.2830
Published: 2012
Journal Articles

Efficacy of Ruxolitinib in Chronic Eosinophilic Leukemia Associated with t(8;9)(p22;p24) and PCM1-JAK2 Fusion Gene.

Ilaria Casetti, Elisa Rumi, MD, Jelena D. Milosevic, Irene Dambruoso, Daniela Pietra, Emanuela Boveri, Marina Boni, Paolo Bernasconi, Francesco Passamonti, Robert Kralovics, Mario Cazzola
Journal: Blood
Blood (2012) 120 (21): 2833.
https://doi.org/10.1182/blood.V120.21.2833.2833
Published: 2012
Journal Articles

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Stefan Ehrentraut, Stefan Nagel, PhD, Michaela Scherr, Bjoern Schneider, Hilmar Quentmeier, PhD, Robert Geffers, PhD, Monika Prochorec-Sobieszek, Rhett P Ketterling, MD, Ryan A Knudson, Andrew L. Feldman, MD, Marshall Kadin, Hans G. Drexler, MD, PhD, Roderick AF MacLeod
Journal: Blood
Blood (2012) 120 (21): 1567.
https://doi.org/10.1182/blood.V120.21.1567.1567
Published: 2012
Journal Articles

Clinical Implications for Patients with Low JAK2V617F Allele Burden

Marguerite Vignon, Dorota Jeziorowska, Pierre Hirsch, MD, Ollivier Legrand, MD, PhD, Nicole Casadevall, MD, Francois Delhommeau, PharmD, PHD, Christophe Marzac, MD
Journal: Blood
Blood (2012) 120 (21): 1745.
https://doi.org/10.1182/blood.V120.21.1745.1745
Published: 2012
Journal Articles

KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis: Results of a Planned Interim Analysis of the Global CPKC412D2201 Trial

Jason Gotlib, MD, MS, Hanneke C. Kluin-Nelemans, MD, PhD, Tracy I. George, MD, Cem Akin, MD, PhD, Karl Sotlar, MD, Olivier Hermine, MD, PhD, Farrukh Awan, MD, MS, Elizabeth Hexner, MD, Michael J. Mauro, MD, Rodica Morariu, MD, Margaret Squier, MD, PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD
Journal: Blood
Blood (2012) 120 (21): 799.
https://doi.org/10.1182/blood.V120.21.799.799
Published: 2012
Journal Articles

Effects of Ponatinib and Other Novel TKI On Growth, Survival, and Function of Neoplastic Eosinophils Carrying FIP1L1/Pdgfra

Irina Sadovnik, M.Sc., Peter Valent, MD, Els Lierman, PhD, Harald Herrmann, M.D., Barbara Peter, D.V.M., Verena Suppan, BSc, Gabriele Stefanzl, MSc, Winfried F Pickl, MD, Jan Cools, PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1760.
https://doi.org/10.1182/blood.V120.21.1760.1760
Published: 2012
Journal Articles

Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/ PCM1-JAK2 –positive chronic eosinophilic leukemia

Els Lierman, Dominik Selleslag, Sanne Smits, Johan Billiet, Peter Vandenberghe
Journal: Blood
Blood (2012) 120 (7): 1529–1531.
https://doi.org/10.1182/blood-2012-06-433821
Published: 2012
Journal Articles

Eosinophilia As a Marker of Strongyloides Infection

Aisha Zaidi, MD, Nagendra Natarajan, MD, MPH, Vivek R. Sharma, MD, FRCPA
Journal: Blood
Blood (2011) 118 (21): 4932.
https://doi.org/10.1182/blood.V118.21.4932.4932
Published: 2011
Journal Articles

Identification of a Novel Mode of Kinase Inhibitor Resistance: An F604S Exchange in FIP1L1-PDGFRA Modulates FIP1L1-PDGFRA Protein Stability in a SHP-2 and SRC-Dependent Manner

Sivahari Prasad Gorantla, Ph.D, Nikolas von Bubnoff, MD, Christian Peschel, MD, Justus Duyster, MD
Journal: Blood
Blood (2011) 118 (21): 1739.
https://doi.org/10.1182/blood.V118.21.1739.1739
Published: 2011
Journal Articles

Long-Term Remission Maintenance on Weekly Imatinib Dosage In Patients with FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukaemia

Grzegorz Helbig, Marek Hus, Andrzej Moskwa, Krystyna Zawilska, MD, PhD, Lucyna Molendowicz-Portala, Alina Świderska, Alina Urbanowicz, Ewa ˙Zuk, Małgorzata Raźny, Marek Rodzaj, Ilona Seferyńska, Małgorzata Całbecka, Ryszard Wichary, Slawomira Kyrcz-Krzemien, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4097.
https://doi.org/10.1182/blood.V116.21.4097.4097
Published: 2010